ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00B53SZB19
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / FundiShares NASDAQ 100 UCITS ETF USD (Acc)
IssuerBlackrock
ETF TickerCNX1(GBX) LSE
ETF TickerSXRV(EUR) F
ETF TickerCNDX.AS(EUR) CXE
ETF TickerCNDX.LS(USD) CXE
ETF TickerCNX1.LS(GBX) CXE
ETF TickerCSNDX.MI(EUR) CXE
ETF TickerCSNDXz(USD) CXE
ETF TickerSXRV.DE(EUR) CXE
ETF TickerCSNDX(EUR) ETF Plus
ETF TickerCNDX(EUR) Euronext Amsterdam
ETF TickerCNX1.L(GBP) LSE

Holdings detail for REGN

Stock NameRegeneron Pharmaceuticals Inc
TickerREGN(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS75886F1075
LEI549300RCBFWIRX3HYQ56

Show aggregate REGN holdings

News associated with REGN

Regeneron And Sanofi : CHMP Recommends EU Approval Of Dupixent For Chronic Spontaneous Urticaria
(RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) and Sanofi announced that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has adopted a positive opinion recommending the approval of Dupixent (dupilumab) in the European Union for treating c - 2025-09-22 02:12:20
Peek Under The Hood: JEPQ Has 10% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-08 08:26:56
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Consensus Rating of “Moderate Buy” by Brokerages
Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the twenty-six analysts that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, six have issued a hold rating, sixteen have assigned a buy rating and three […] - 2025-08-26 02:16:48
LABU, INCY, UTHR, REGN: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Regeneron Pharmaceuticals (NASDAQ:REGN) versus Cadrenal Therapeutics (NASDAQ:CVKD) Head-To-Head Analysis
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) and Cadrenal Therapeutics (NASDAQ:CVKD – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability and earnings. Volatility and Risk Regeneron Pharmaceuticals has a beta […] - 2025-08-20 02:22:48
Truist Financial Cuts Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $812.00
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target reduced by Truist Financial from $940.00 to $812.00 in a research note published on Monday,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. REGN has been the topic of several other reports. The Goldman Sachs Group dropped their price target on […] - 2025-08-14 03:00:52
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Position Raised by Blair William & Co. IL
Blair William & Co. IL lifted its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.2% in the 1st quarter, Holdings Channel reports. The fund owned 1,282 shares of the biopharmaceutical company’s stock after buying an additional 27 shares during the period. Blair William & Co. IL’s holdings in Regeneron Pharmaceuticals were worth […] - 2025-08-11 06:26:50
Harbour Investments Inc. Sells 32 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Harbour Investments Inc. reduced its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 7.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 403 shares of the biopharmaceutical company’s stock after selling 32 shares during the quarter. Harbour Investments Inc.’s holdings in […] - 2025-08-07 09:40:47
We Did The Math SPYX Can Go To $58
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-07 08:58:54
409 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Purchased by Arkadios Wealth Advisors
Arkadios Wealth Advisors purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 409 shares of the biopharmaceutical company’s stock, valued at approximately $259,000. Several other institutional investors and hedge funds also […] - 2025-08-07 05:38:53
Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price Expected to Rise, BMO Capital Markets Analyst Says
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its price target upped by stock analysts at BMO Capital Markets from $600.00 to $640.00 in a research report issued on Monday,Benzinga reports. The firm currently has an “outperform” rating on the biopharmaceutical company’s stock. BMO Capital Markets’ price target indicates a potential upside of 12.30% from […] - 2025-08-06 03:12:48
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives $828.86 Consensus Target Price from Brokerages
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has been given a consensus rating of “Moderate Buy” by the twenty-four ratings firms that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation, fifteen have assigned a buy recommendation and two […] - 2025-08-04 02:59:01
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 19:31:54
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:40:40
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:35:36
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:02:25
Nasdaq 100 Movers: MRVL, REGN
In early trading on Friday, shares of Regeneron Pharmaceuticals, topped the list of the day's best performing components of the Nasdaq 100 index, trading up 3.6%. Year to date, Regeneron Pharmaceuticals, has lost about 20.7% of its value. And the worst performing Nasdaq 100 co - 2025-08-01 11:30:09
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Choreo LLC
Choreo LLC boosted its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,746 shares of the biopharmaceutical company’s stock after acquiring an additional 32 shares during the period. Choreo LLC’s holdings in Regeneron Pharmaceuticals […] - 2025-07-24 07:22:56
Crestwood Advisors Group LLC Grows Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Crestwood Advisors Group LLC increased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 467 shares of the biopharmaceutical company’s stock after purchasing an additional 25 shares during the quarter. Crestwood Advisors Group […] - 2025-07-24 05:47:12
Kestra Private Wealth Services LLC Has $1.31 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Kestra Private Wealth Services LLC grew its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.9% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,058 shares of the biopharmaceutical company’s stock after buying an additional 132 shares during the quarter. […] - 2025-07-23 07:50:58
Larson Financial Group LLC Has $34,000 Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Larson Financial Group LLC lessened its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 34.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 53 shares of the biopharmaceutical company’s stock after selling 28 shares during the quarter. Larson […] - 2025-07-23 06:30:53
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Alps Advisors Inc.
Alps Advisors Inc. raised its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 71.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 530 shares of the biopharmaceutical company’s stock after purchasing an additional 220 shares during the quarter. Alps Advisors Inc.’s […] - 2025-07-17 05:50:54
Stratos Wealth Partners LTD. Sells 115 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Stratos Wealth Partners LTD. trimmed its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 18.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 506 shares of the biopharmaceutical company’s stock after selling 115 shares during the period. Stratos Wealth Partners […] - 2025-07-16 04:58:54
Allworth Financial LP Reduces Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Allworth Financial LP trimmed its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 14.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 821 shares of the biopharmaceutical company’s stock after selling 137 shares during the period. Allworth Financial […] - 2025-07-15 08:20:00
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $584.00
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target increased by UBS Group from $560.00 to $584.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. Several other research analysts also recently commented on REGN. BMO Capital Markets reduced their price objective on Regeneron […] - 2025-07-14 03:30:48
Brown Advisory Inc. Reduces Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Brown Advisory Inc. lowered its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,269 shares of the biopharmaceutical company’s stock after selling 247 shares during the quarter. Brown Advisory Inc.’s […] - 2025-07-13 05:54:54
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Holdings Cut by D.A. Davidson & CO.
D.A. Davidson & CO. reduced its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.8% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 732 shares of the biopharmaceutical company’s stock after selling 21 shares during the quarter. D.A. […] - 2025-07-11 05:32:52
Brokerages Set Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) PT at $813.57
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has received an average recommendation of “Moderate Buy” from the twenty-five ratings firms that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, six have issued a hold rating, fifteen have assigned a buy rating and three have issued […] - 2025-07-10 03:07:00
DAVENPORT & Co LLC Makes New Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
DAVENPORT & Co LLC purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 427 shares of the biopharmaceutical company’s stock, valued at approximately $271,000. A number of other institutional […] - 2025-07-09 05:11:22
Bessemer Group Inc. Sells 3,860 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Bessemer Group Inc. decreased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 76.0% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,218 shares of the biopharmaceutical company’s stock after selling 3,860 shares during the period. Bessemer Group […] - 2025-07-01 05:46:52

iShares NASDAQ 100 UCITS ETF USD (Acc) REGN holdings

DateNumber of REGN Shares HeldBase Market Value of REGN SharesLocal Market Value of REGN SharesChange in REGN Shares HeldChange in REGN Base ValueCurrent Price per REGN Share HeldPrevious Price per REGN Share Held
2025-12-03 (Wednesday)129,820USD 93,946,839USD 93,946,839
2025-12-02 (Tuesday)129,484REGN holding increased by 12USD 96,077,128REGN holding decreased by -1041114USD 96,077,12812USD -1,041,114 USD 742 USD 750.11
2025-12-01 (Monday)129,472REGN holding decreased by -96USD 97,118,242REGN holding decreased by -3969416USD 97,118,242-96USD -3,969,416 USD 750.11 USD 780.19
2025-11-28 (Friday)129,568REGN holding increased by 48USD 101,087,658REGN holding decreased by -535029USD 101,087,65848USD -535,029 USD 780.19 USD 784.61
2025-11-27 (Thursday)129,520USD 101,622,687USD 101,622,6870USD 0 USD 784.61 USD 784.61
2025-11-26 (Wednesday)129,520REGN holding increased by 48USD 101,622,687REGN holding decreased by -313208USD 101,622,68748USD -313,208 USD 784.61 USD 787.32
2025-11-25 (Tuesday)129,472REGN holding increased by 24USD 101,935,895REGN holding increased by 3367715USD 101,935,89524USD 3,367,715 USD 787.32 USD 761.45
2025-11-24 (Monday)129,448REGN holding increased by 12USD 98,568,180REGN holding increased by 727508USD 98,568,18012USD 727,508 USD 761.45 USD 755.9
2025-11-21 (Friday)129,436REGN holding increased by 48USD 97,840,672REGN holding increased by 2481716USD 97,840,67248USD 2,481,716 USD 755.9 USD 737
2025-11-20 (Thursday)129,388REGN holding increased by 216USD 95,358,956REGN holding increased by 4583333USD 95,358,956216USD 4,583,333 USD 737 USD 702.75
2025-11-19 (Wednesday)129,172REGN holding decreased by -12USD 90,775,623REGN holding decreased by -2926700USD 90,775,623-12USD -2,926,700 USD 702.75 USD 725.34
2025-11-18 (Tuesday)129,184REGN holding decreased by -324USD 93,702,323REGN holding increased by 2488544USD 93,702,323-324USD 2,488,544 USD 725.34 USD 704.31
2025-11-17 (Monday)129,508REGN holding decreased by -132USD 91,213,779REGN holding increased by 1308439USD 91,213,779-132USD 1,308,439 USD 704.31 USD 693.5
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of REGN by Blackrock for IE00B53SZB19

Show aggregate share trades of REGN

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-12-02BUY12 742.000* 643.53
2025-12-01SELL-96779.840748.210 751.373USD -72,132 643.04 Loss of -10,400 on sale
2025-11-28BUY48 780.190* 642.42
2025-11-26BUY48790.980777.000 778.398USD 37,363 641.11
2025-11-26BUY48790.980777.000 778.398USD 37,363 641.11
2025-11-25BUY24790.570760.700 763.687USD 18,328 640.44
2025-11-24BUY12773.130756.640 758.289USD 9,099 639.88
2025-11-21BUY48 755.900* 639.34
2025-11-20BUY216 737.000* 638.89
2025-11-19SELL-12 702.750* 638.59 Profit of 7,663 on sale
2025-11-18SELL-324 725.340* 638.18 Profit of 206,769 on sale
2025-11-17SELL-132711.880692.290 694.249USD -91,641 637.86 Loss of -7,443 on sale
2025-11-14SELL-120699.270686.000 687.327USD -82,479 637.60 Loss of -5,968 on sale
2025-11-13BUY24713.580679.930 683.295USD 16,399 637.32
2025-11-07BUY60 657.530* 636.74
2025-11-06SELL-24657.000641.260 642.834USD -15,428 636.69 Loss of -147 on sale
2025-11-04BUY96646.221625.140 627.248USD 60,216 636.70
2025-11-03SELL-1,775657.460627.500 630.496USD -1,119,130 636.67 Profit of 10,959 on sale
2025-10-30BUY324664.000645.000 646.900USD 209,596 636.58
2025-10-29BUY252652.910659.980 659.273USD 166,137 636.50
2025-10-28BUY192654.480655.700 655.578USD 125,871 636.41
2025-10-27SELL-96585.310586.150 586.066USD -56,262 636.67 Profit of 4,858 on sale
2025-10-24BUY36577.950582.700 582.225USD 20,960 636.97
2025-10-23SELL-96575.690584.000 583.169USD -55,984 637.28 Profit of 5,195 on sale
2025-10-22BUY72584.740588.710 588.313USD 42,359 637.55
2025-10-21BUY108579.340582.410 582.103USD 62,867 637.86
2025-10-20SELL-360576.770582.650 582.062USD -209,542 638.17 Profit of 20,200 on sale
2025-10-17SELL-36578.050579.040 578.941USD -20,842 638.49 Profit of 2,144 on sale
2025-10-16BUY96569.170589.080 587.089USD 56,361 638.85
2025-10-14SELL-84572.600576.180 575.822USD -48,369 639.54 Profit of 5,352 on sale
2025-10-13BUY168557.730563.770 563.166USD 94,612 639.98
2025-10-02BUY396600.000605.410 604.869USD 239,528 640.19
2025-09-30BUY48562.270574.040 572.863USD 27,497 640.61
2025-09-29BUY72560.750564.910 564.494USD 40,644 641.05
2025-09-26BUY36563.900564.610 564.539USD 20,323 641.47
2025-09-25BUY36555.510579.000 576.651USD 20,759 641.94
2025-09-18BUY300598.710600.000 599.871USD 179,961 642.18
2025-09-17BUY372585.500587.670 587.453USD 218,533 642.49
2025-09-16BUY144575.060579.400 578.966USD 83,371 642.87
2025-09-11BUY96568.200570.760 570.504USD 54,768 643.76
2025-08-29BUY144580.700581.250 581.195USD 83,692 645.50
2025-08-22SELL-12589.480610.450 608.353USD -7,300 645.83 Profit of 450 on sale
2025-08-21SELL-48598.160605.180 604.478USD -29,015 646.11 Profit of 1,998 on sale
2025-08-20BUY36591.010596.920 596.329USD 21,468 646.43
2025-08-19BUY120571.780581.690 580.699USD 69,684 646.87
2025-08-15BUY360580.410581.950 581.796USD 209,447 647.71
2025-08-13BUY288561.550565.500 565.105USD 162,750 648.23
2025-08-12BUY48556.550562.740 562.121USD 26,982 648.78
2025-08-05BUY84569.900579.820 578.828USD 48,622 649.84
2025-08-04SELL-12571.540577.210 576.643USD -6,920 650.32 Profit of 884 on sale
2025-07-31SELL-1,775545.460558.130 556.863USD -988,432 651.55 Profit of 168,070 on sale
2025-07-30BUY96554.580563.590 562.689USD 54,018 652.16
2025-07-28BUY96558.630567.950 567.018USD 54,434 653.35
2025-07-17SELL-147550.000554.480 554.032USD -81,443 654.60 Profit of 14,784 on sale
2025-07-15BUY49547.960574.750 572.071USD 28,031 656.00
2025-07-14BUY49570.590575.130 574.676USD 28,159 656.56
2025-07-11BUY49567.740568.460 568.388USD 27,851 657.15
2025-07-09BUY98552.580558.380 557.800USD 54,664 657.85
2025-07-08SELL-49547.750559.460 558.289USD -27,356 658.58 Profit of 4,914 on sale
2025-07-02SELL-49547.740551.500 551.124USD -27,005 661.71 Profit of 5,419 on sale
2025-07-01BUY294534.910548.040 546.727USD 160,738 662.59
2025-06-26BUY294521.000524.520 524.168USD 154,105 664.59
2025-06-25BUY484520.290525.630 525.096USD 254,146 665.61
2025-06-24BUY98522.270527.450 526.932USD 51,639 666.64
2025-06-18BUY96513.580519.170 518.611USD 49,787 668.85
2025-06-17BUY49508.860523.010 521.595USD 25,558 670.02
2025-06-16SELL-240522.680538.200 536.648USD -128,796 671.11 Profit of 32,270 on sale
2025-06-13BUY49529.240529.550 529.519USD 25,946 672.16
2025-06-12SELL-196521.840525.220 524.882USD -102,877 673.28 Profit of 29,086 on sale
2025-06-06BUY49493.220499.880 499.214USD 24,461 678.20
2025-06-05BUY96483.070491.770 490.900USD 47,126 679.71
2025-06-04BUY98484.930499.900 498.403USD 48,843 681.24
2025-06-03BUY1,176487.860501.110 499.785USD 587,747 682.76
2025-06-02BUY49490.810502.560 501.385USD 24,568 684.28
2025-05-30BUY194490.280519.780 516.830USD 100,265 685.83
2025-05-29SELL-49605.390605.730 605.696USD -29,679 686.48 Profit of 3,959 on sale
2025-05-28SELL-49591.850606.000 604.585USD -29,625 687.25 Profit of 4,051 on sale
2025-05-23SELL-98588.340591.640 591.310USD -57,948 689.60 Profit of 9,633 on sale
2025-05-22SELL-392596.850605.500 604.635USD -237,017 690.38 Profit of 33,612 on sale
2025-05-20SELL-48614.790615.450 615.384USD -29,538 691.76 Profit of 3,666 on sale
2025-05-19BUY96596.540598.560 598.358USD 57,442 692.58
2025-05-16SELL-1,903594.320595.190 595.103USD -1,132,481 693.43 Profit of 187,126 on sale
2025-05-15BUY441584.990585.260 585.233USD 258,088 694.39
2025-05-14BUY98571.360580.560 579.640USD 56,805 695.47
2025-05-13BUY441574.160575.050 574.961USD 253,558 696.56
2025-05-12BUY343575.630577.990 577.754USD 198,170 697.65
2025-05-08BUY147547.670552.570 552.080USD 81,156 700.58
2025-05-02BUY98605.610615.610 614.610USD 60,232 705.09
2025-04-29BUY196568.910579.980 578.873USD 113,459 708.60
2025-04-28BUY343610.860614.830 614.433USD 210,751 709.57
2025-04-25BUY147602.640602.790 602.775USD 88,608 710.64
2025-04-24BUY98599.760601.280 601.128USD 58,911 711.76
2025-04-23BUY98587.850603.770 602.178USD 59,013 713.02
2025-04-22BUY343585.490587.100 586.939USD 201,320 714.34
2025-04-16BUY98549.280561.830 560.575USD 54,936 721.00
2025-04-15BUY245557.910575.200 573.471USD 140,500 722.78
2025-04-14BUY588571.060574.720 574.354USD 337,720 724.44
2025-04-11BUY200554.180555.530 555.395USD 111,079 726.34
2025-04-09BUY550576.720580.730 580.329USD 319,181 730.08
2025-04-08BUY1,000556.810586.030 583.108USD 583,108 732.07
2025-04-04SELL-650573.450612.990 609.036USD -395,873 735.81 Profit of 82,405 on sale
2025-04-02SELL-50625.600628.000 627.760USD -31,388 737.13 Profit of 5,468 on sale
2025-04-01SELL-50617.000641.240 638.816USD -31,941 738.57 Profit of 4,988 on sale
2025-03-31SELL-344634.230640.720 640.071USD -220,184 739.85 Profit of 34,322 on sale
2025-03-26BUY444640.140644.000 643.614USD 285,765 743.72
2025-03-25BUY547634.140662.570 659.727USD 360,871 745.13
2025-03-24BUY150661.000667.460 666.814USD 100,022 746.22
2025-03-21BUY50658.480661.000 660.748USD 33,037 747.37
2025-03-20BUY100662.620674.830 673.609USD 67,361 748.50
2025-03-19BUY391672.360674.570 674.349USD 263,670 749.53
2025-03-18BUY100664.960678.270 676.939USD 67,694 750.69
2025-03-17SELL-150678.420679.830 679.689USD -101,953 751.69 Profit of 10,801 on sale
2025-03-14BUY250666.870686.980 684.969USD 171,242 752.89
2025-03-13BUY100680.610698.950 697.116USD 69,712 753.92
2025-03-11SELL-280718.160747.700 744.746USD -208,529 755.39 Profit of 2,982 on sale
2025-03-10SELL-250744.830748.290 747.944USD -186,986 755.55 Profit of 1,902 on sale
2025-03-06SELL-250698.440701.000 700.744USD -175,186 757.17 Profit of 14,107 on sale
2025-03-05SELL-100687.150692.790 692.226USD -69,223 758.26 Profit of 6,604 on sale
2025-03-04SELL-450675.490697.460 695.263USD -312,868 759.58 Profit of 28,942 on sale
2025-03-03SELL-235684.870704.640 702.663USD -165,126 760.78 Profit of 13,658 on sale
2025-02-28SELL-145698.740708.580 707.596USD -102,601 761.80 Profit of 7,860 on sale
2025-02-25SELL-200723.470739.000 737.447USD -147,489 764.42 Profit of 5,396 on sale
2025-02-20SELL-100696.020703.140 702.428USD -70,243 767.76 Profit of 6,534 on sale
2025-02-19SELL-300685.660688.670 688.369USD -206,511 769.28 Profit of 24,275 on sale
2025-02-18SELL-150680.000689.950 688.955USD -103,343 770.97 Profit of 12,302 on sale
2025-02-13BUY100674.270677.690 677.348USD 67,735 776.80
2025-02-07BUY100710.000731.420 729.278USD 72,928 785.00
2025-01-29BUY200687.270697.570 696.540USD 139,308 801.65
2025-01-28BUY50686.330690.300 689.903USD 34,495 804.68
2025-01-27SELL-5684.710698.450 697.076USD -3,485 807.92 Profit of 554 on sale
2025-01-24BUY150675.790693.840 692.035USD 103,805 811.59
2025-01-23SELL-2,100694.640696.190 696.035USD -1,461,674 814.94 Profit of 249,690 on sale
2025-01-22BUY145680.030699.880 697.895USD 101,195 818.90
2024-12-10BUY49778.500791.490 790.191USD 38,719 820.13
2024-12-09SELL-343788.000800.990 799.691USD -274,294 821.13 Profit of 7,354 on sale
2024-12-06BUY196778.000778.120 778.108USD 152,509 822.52
2024-12-05BUY49767.900768.020 768.008USD 37,632 824.34
2024-12-03SELL-196749.570770.000 767.957USD -150,520 829.52 Profit of 12,066 on sale
2024-12-02BUY98762.340763.890 763.735USD 74,846 832.00
2024-11-29BUY144750.220754.510 754.081USD 108,588 835.15
2024-11-27BUY98754.870762.160 761.431USD 74,620 841.84
2024-11-26BUY49753.030754.180 754.065USD 36,949 845.70
2024-11-22BUY150738.000751.400 750.060USD 112,509 855.41
2024-11-21BUY49744.500757.560 756.254USD 37,056 860.96
2024-11-19BUY147744.600758.600 757.200USD 111,308 873.95
2024-11-18SELL-507762.000762.700 762.630USD -386,653 880.54 Profit of 59,780 on sale
2024-11-12BUY196821.000831.000 830.000USD 162,680 884.26
2024-11-08BUY49828.420830.730 830.499USD 40,694 892.43
2024-11-07BUY1,225824.480832.530 831.725USD 1,018,863 897.66
2024-11-06BUY147816.650844.510 841.724USD 123,733 904.41
2024-11-05BUY49829.430836.630 835.910USD 40,960 911.23
2024-11-04BUY98828.840852.010 849.693USD 83,270 919.47
2024-10-25BUY98933.020943.830 942.749USD 92,389 950.28
2024-10-24SELL-98928.900952.020 949.708USD -93,071 957.41 Profit of 755 on sale
2024-10-21BUY147968.500991.240 988.966USD 145,378 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of REGN

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19208,6591,635312,81266.7%
2025-09-18236,4853,679387,51961.0%
2025-09-17229,191716370,89561.8%
2025-09-16173,632584271,02064.1%
2025-09-15204,491251334,49661.1%
2025-09-12117,50433222,76052.7%
2025-09-11125,4783,137286,51643.8%
2025-09-10195,068481339,88557.4%
2025-09-09129,168994274,52047.1%
2025-09-08250,895396527,06247.6%
2025-09-05170,149290289,56658.8%
2025-09-04188,2272,103360,61952.2%
2025-09-03185,679344438,11142.4%
2025-09-02191,954138476,28840.3%
2025-08-29133,226685236,72656.3%
2025-08-28116,5602,177256,67545.4%
2025-08-27113,719465243,83646.6%
2025-08-26210,376450400,19952.6%
2025-08-25149,13068363,37741.0%
2025-08-22211,8223,244701,77030.2%
2025-08-21257,4923,416446,43957.7%
2025-08-20327,738572559,13358.6%
2025-08-19118,4722,191324,31136.5%
2025-08-18146,282388277,90952.6%
2025-08-15209,9233,375441,75247.5%
2025-08-14157,5693,623429,32736.7%
2025-08-13111,342233362,78630.7%
2025-08-12117,647171310,77537.9%
2025-08-11129,5132,676284,75745.5%
2025-08-08128,5591,038431,84129.8%
2025-08-07166,6481,560352,87747.2%
2025-08-06176,311624397,08944.4%
2025-08-05154,257115353,74443.6%
2025-08-04200,7581,913409,89749.0%
2025-08-01349,7753,745728,72048.0%
2025-07-31222,350476549,34440.5%
2025-07-30106,8391,689231,76146.1%
2025-07-29149,359276292,66751.0%
2025-07-28103,6871,380245,28742.3%
2025-07-25103,783556259,06940.1%
2025-07-24156,9742,397291,67753.8%
2025-07-23168,7341,708355,37247.5%
2025-07-22116,324617304,88038.2%
2025-07-2198,482900250,10739.4%
2025-07-18183,1741,051391,90946.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy